InvestorsHub Logo
icon url

Rdunn88

05/18/21 1:23 PM

#359665 RE: Longpicker #359662

Data release will be another 4 or 5 weeks after subject 120... There's a post 29 day observation built into the trial... 70 percent of 120 is 84, so IPIX is averaging 8 recruits per/week... Guessing trial completion in 6 weeks,results in August. Emergency use will be the key driver if results are good/great. Phase 3 will be too long await to be worth the costs.
icon url

Jhawker

05/18/21 1:24 PM

#359666 RE: Longpicker #359662

I am sure we will have top line before that
icon url

loanranger

05/18/21 3:17 PM

#359685 RE: Longpicker #359662

"Anticipated Study Completion Date :
Jul 1, 2021

That’s pretty early in July."


It sure is. It's also not what the real source says:
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : July 2021
https://clinicaltrials.gov/ct2/show/NCT04784897?term=brilacidin&draw=2&rank=2

The nifty new website may be easy to read but it looks like it's not so reliable.


(Thanks, FatA!)